Sanofi's deep partnership with OpenAI could be a huge differentiating factor. Check out why I rate SNY stock a buy.

The biosimilars reach the US market as the US insulin space has seen seismic changes in the last few years, with a clamour of ...

Today, a brief rundown of news involving Novartis and AbbVie, as well as updates from Biogen, Merck & Co. and Sanofi that you may have missed. Expected readouts in diabetes, cancer and depression ...

The oversubscribed series B financing was co-led by EQT Life Sciences and Sanofi Ventures, according to a Jan. 28 release. Existing investor F-Prime Capital also joined the round, with ...

Patients to pay no more than $35 a month Eli Lilly, Sanofi previously settled overcharging claims Novo Nordisk denies wrongdoing, pledges affordable insulin Jan 27 (Reuters) - Novo Nordisk (NOVOb ...

HealthDay News — The U.S. Food and Drug Administration has warned the pharmaceutical company Sanofi about significant deviations from Current Good Manufacturing Practice for active pharmaceutical ...

(HealthDay News) — The US Food and Drug Administration (FDA) has warned Sanofi about significant deviations from Current Good Manufacturing Practice regulations for active pharmaceutical ...

The FDA issued a warning letter to Sanofi regarding significant manufacturing violations at its Genzyme Corporation Facility in Framingham, Mass. The letter, dated Dec. 16, 2024, and amended Jan ...

The US Food and Drug Administration has issued a warning letter to French drugmaker Sanofi (Euronext: SAN) following an inspection of its Massachusetts manufacturing site. The missive raises concerns ...

The Food and Drug Administration has warned Sanofi about a series of “significant” manufacturing problems, including contamination, at a key facility in Massachusetts where the company makes ...

Welcome to the Sanofi Presentation at the 43rd J.P. Morgan ... And we are 100% by the way focused on financial discipline, my background especially, but also much more broadly in the company ...